Walleye Capital’s Cardio Diagnostics Holdings Inc Warrant CDIOW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-234,907
Closed -$9.14K 4908
2024
Q3
$9.14K Hold
234,907
﹤0.01% 4930
2024
Q2
$9.14K Hold
234,907
﹤0.01% 5241
2024
Q1
$25K Hold
234,907
﹤0.01% 4866
2023
Q4
$40.9K Buy
234,907
+11,520
+5% +$1.15K ﹤0.01% 4347
2023
Q3
$7.82K Hold
223,387
﹤0.01% 4515
2023
Q2
$42.1K Sell
223,387
-968
-0.4% -$177 ﹤0.01% 3671
2023
Q1
$71.8K Buy
224,355
+181,440
+423% +$42.6K ﹤0.01% 3072
2022
Q4
$2.12K Buy
+42,915
New +$5.11K ﹤0.01% 2978

Other funds holding CDIOW

Walleye Capital's CDIOW Position: Q4 2024 in Review

Walleye Capital sold out of Cardio Diagnostics Holdings Inc Warrant (CDIOW) in Q4 2024, closing a stake of 234,907 shares — an estimated $9.14K sold.

Walleye Capital first reported a position in CDIOW in Q4 2022 and held it in 8 quarters. The position peaked at $71.8K in Q1 2023. 6 funds tracked by Wall St. Rank hold CDIOW as of Q4 2024.

  • Walleye Capital reported no remaining Cardio Diagnostics Holdings Inc Warrant position as of Q4 2024 after selling out during the quarter.
  • Walleye Capital sold 234,907 Cardio Diagnostics Holdings Inc Warrant shares in Q4 2024, an estimated $9.14K.
  • Walleye Capital first reported a position in Cardio Diagnostics Holdings Inc Warrant in Q4 2022 and held it in 8 quarters.
  • Walleye Capital's Cardio Diagnostics Holdings Inc Warrant position peaked at $71.8K in Q1 2023.
  • 6 funds tracked by Wall St. Rank held Cardio Diagnostics Holdings Inc Warrant as of Q4 2024.

Based on Walleye Capital's 13F filing for Q4 2024, filed 13 Feb 2025.